{"id":447416,"title":"Guidance Document: Tamper-resistance Formulations of Opioid Drug Products - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-03","captureTimestamp":"2026-01-03T14:24:12.474000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/tamper-resistance-formulations-opioid-drug-products.html?wbdisable=false","snippet":"Guidance Document: Tamper-resistance Formulations of Opioid Drug Products (PDF Version - 109 K) Date adopted: 2016/03/10 Effective Date: 2016/03/30 Foreword Guidance documents are meant to provide assistance to industry and health care professionals on how to comply with…","rawSnapshotUrl":"/api/snapshots/raw/447416","browseUrl":"https://replay.healtharchive.ca/job-6/20260103142412/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/tamper-resistance-formulations-opioid-drug-products.html?wbdisable=false#ha_snapshot=447416","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}